| abstract |
The present invention, at least one direct thrombin inhibitor, antiplatelet agent, low molecular weight heparin (LMWH) and heparinoids as well as unfractionated heparin, factor X a inhibitor, bound thrombin / factor X a inhibitors , At least one additional active ingredient compound selected from the group consisting of a fibrinogen receptor antagonist (glycoprotein IIb / IIa antagonist) and a vitamin K antagonist, and optionally further one or more pharmaceuticals The present invention relates to a novel pharmaceutical composition for treating thrombosis, which may contain a pharmaceutically acceptable excipient or carrier. |